Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Switch to CAD Technology Greatly Improves Lab-On-A-Chip Capability

By BiotechDaily International staff writers
Posted on 12 May 2014
The lab-on-a-chip holds potential for reducing cost of medical diagnostics while expanding access to health care. Now scientists have developed computer aided design (CAD) software to enable far more than one or two tests on a single chip.

In the near future healthcare professionals may be able to routinely run clinical lab tests almost instantly on a digital microfluidic machine about the size of credit card. These lab-on-a-chips (LOCs) would not only be quick—results available in minutes—but also inexpensive and portable. They could be used at point-of-care, and even at long distance from the nearest medical clinic.

But as powerful as they may be, they could be far better, said Shiyan Hu, associate professor of electrical and computer engineering at Michigan Technological University (MTU; Houghton, MI, USA). Current LOCs can generally run no more than a test or two because the chips are designed manually. If the LOCs were made using computer-aided design (CAD), you could run dozens of tests with, for example, a single drop of blood. “In a very short time, you could test for many conditions,” said Prof. Hu; “This really would be an entire lab on a chip.” With PhD student Chen Liao, Prof. Hu has taken the first step. “We have developed software to design the hardware,” he said.

Their work, described in, and featured on the cover of, the March, 2014, edition of the journal IEEE Transactions on Nanobiosciences, focuses on routing a droplet of blood or other fluid through each test on the chip efficiently while avoiding contamination. A key part in LOC CAD is physical-level synthesis. It includes the LOC placement and routing, where placement is to determine the physical location and the starting time of each operation, and routing is to transport each droplet from the source to the destination.

“It has taken us four years to do the software, but to manufacture the LOC would be inexpensive,” said Prof. Hu; “The materials are very cheap, and the results are more accurate than a conventional lab’s.” Prof. Hu plans to fabricate their own biochip using their software.

Related Links:

Michigan Technological University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.